FDA Adverse Event Other Summary report: N

ADVIA CENTAUR XP

MDR report key: 1366360 · Received April 20, 2009

Report

Report Number
2432235-2009-00082
Event Type
Other
Date Received
April 20, 2009
Date of Event
March 26, 2009
Report Date
March 31, 2009
Manufacturer
SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K971418
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SIEMENS FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE. ANALYSIS OF THE INSTRUMENT AND INSTRUMENT DATA INDICATE THAT THE CAUSE OF THE DISCREPANT HCV RESULTS WERE DUE TO THE CUSTOMER NOT USING THE RECOMMENDED SAMPLE TUBE TYPES. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 1

DISCREPANT CENTAUR XP HCV RESULTS WERE OBTAINED ON PT SAMPLES. THE DISCREPANT RESULTS WERE NOT REPORTED TO THE PHYSICIAN. THE SAMPLES WERE RETESTED AND THE CORRECT RESULTS WERE REPORTED. THERE ARE NO REPORTS OF PT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCREPANT RESULTS.

Additional Manufacturer Narrative · 2

A SIEMENS FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE. ANALYSIS OF THE INSTRUMENT AND INSTRUMENT DATA INDICATE THAT THE CAUSE OF THE DISCREPANT HCV RESULTS WERE DUE TO THE CUSTOMER NOT USING THE RECOMMENDED SAMPLE TUBE TYPES. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 2

DISCREPANT CENTAUR XP HCV RESULTS WERE OBTAINED ON PT SAMPLES. THE DISCREPANT RESULTS WERE NOT REPORTED TO THE PHYSICIAN. THE SAMPLES WERE RETESTED AND THE CORRECT RESULTS WERE REPORTED. THERE ARE NO REPORTS OF PT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCREPANT RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR XP IMMUNO-ASSAY ANALYZER JJE SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1
2